Upon completion of this module, learners will be able to: Part 2: 1. Describe indications for use of immunosuppressant therapy in glomerulonephritis 2. Identify and describe novel agents used to reduce toxicities of traditional agents
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
16 of 16 courses listed here are free.
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Online course / module
- Credit · Up to 0.5 credits
-
ReleasedApr 8, 2026
-
Last day to claim creditApr 9, 2029 2 years left
-
Advancing Kidney Health through Optimal Medication Management +1 AKHOMM: Primer on Immunosuppressants used in Glomerular Disease, Part 1 Basics and Traditional Immunosuppressants
-
Advancing Kidney Health through Optimal Medication Management (AKHOMM) +1 AKHOMM: Clinical Approach and Emerging Therapeutics for Focal Segmental Glomerulosclerosis (FSGS)
-
Advancing Kidney Health through Optimal Medication Management (AKHOMM) +1 AKHOMM Primer on Immunosuppressants used in Glomerular Disease, Targeting IgA Nephropathy: Insights into Pathogenesis, Novel Therapies, and Clinical Application
